We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$21.2B
AUM Growth
+$1.07B
(+5.3%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
9.44%
Holding
1,639
New
311
Increased
467
Reduced
550
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$211M |
| 2 |
AbbVie
ABBV
|
+$176M |
| 3 |
Apple
AAPL
|
+$170M |
| 4 |
Nike
NKE
|
+$161M |
| 5 |
Coca-Cola
KO
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$221M |
| 2 |
Medtronic
MDT
|
+$163M |
| 3 |
UnitedHealth
UNH
|
+$148M |
| 4 |
Johnson & Johnson
JNJ
|
+$133M |
| 5 |
Pfizer
PFE
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Consumer Discretionary | 14.98% |
| 3 | Healthcare | 13.91% |
| 4 | Financials | 10.93% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PYCR
1151
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $848K | ﹤0.01% |
+35,815
| New | +$835K |
|
1152
WD-40
WDFC
$3.09B
| $846K | ﹤0.01% |
4,483
-10,231
| -70% | -$1.93M |
|
1153
Chemours
CC
$2.3B
| $845K | ﹤0.01% |
22,893
+9,566
| +72% | +$292K |
|
|
ERF
1154
DELISTED
Enerplus Corporation
ERF
| $831K | ﹤0.01% |
57,434
+43,259
| +305% | +$631K |
|
|
OPI
1155
DELISTED
Office Properties Income Trust
OPI
| $823K | ﹤0.01% |
+106,859
| New | +$809K |
|
1156
Tradeweb Markets
TW
$22.3B
| $818K | ﹤0.01% |
+11,938
| New | +$846K |
|
1157
Sturm, Ruger & Co
RGR
$601M
| $815K | ﹤0.01% |
+15,386
| New | +$839K |
|
1158
Lithia Motors
LAD
$8.32B
| $803K | ﹤0.01% |
2,639
-76,737
| -97% | -$18.4M |
|
1159
HubSpot
HUBS
$12B
| $795K | ﹤0.01% |
+1,495
| New | +$701K |
|
1160
Navient
NAVI
$867M
| $792K | ﹤0.01% |
42,602
-192,149
| -82% | -$3.16M |
|
1161
Zymeworks
ZYME
$1.83B
| $785K | ﹤0.01% |
90,803
-162,401
| -64% | -$1.45M |
|
1162
Corcept Therapeutics
CORT
$11.9B
| $784K | ﹤0.01% |
35,237
-29,143
| -45% | -$671K |
|
1163
Teradata
TDC
$2.57B
| $780K | ﹤0.01% |
+14,601
| New | +$658K |
|
|
AXNX
1164
DELISTED
Axonics, Inc. Common Stock
AXNX
| $769K | ﹤0.01% |
+15,230
| New | +$810K |
|
1165
Vistra
VST
$49.1B
| $764K | ﹤0.01% |
+29,108
| New | +$711K |
|
1166
Chunghwa Telecom
CHT
$32.8B
| $762K | ﹤0.01% |
20,444
-35,473
| -63% | -$1.44M |
|
1167
Four Corners Property Trust
FCPT
$2.76B
| $759K | ﹤0.01% |
+29,885
| New | +$773K |
|
|
HIBB
1168
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $758K | ﹤0.01% |
20,878
-19,500
| -48% | -$932K |
|
1169
CTS Corp
CTS
$1.79B
| $756K | ﹤0.01% |
17,738
+8,870
| +100% | +$390K |
|
1170
Methanex
MEOH
$4.19B
| $754K | ﹤0.01% |
+18,229
| New | +$787K |
|
1171
Alaska Air
ALK
$5.3B
| $753K | ﹤0.01% |
+14,167
| New | +$644K |
|
1172
Compañía de Minas Buenaventura
BVN
$8.55B
| $753K | ﹤0.01% |
102,448
-204,068
| -67% | -$1.5M |
|
1173
Ally Financial
ALLY
$13.6B
| $751K | ﹤0.01% |
27,807
-543,933
| -95% | -$14.5M |
|
1174
Grupo Aeroportuario Centro Norte
OMAB
$5.19B
| $747K | ﹤0.01% |
+8,801
| New | +$759K |
|
1175
PTC
PTC
$16.7B
| $746K | ﹤0.01% |
+5,244
| New | +$695K |
|
Similar funds
VAI
JG
OAG
Voloridge Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, Voloridge Investment Management held 1,639 positions worth $21.2B, up 5.3% from $20.1B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Voloridge Investment Management's Q2 2023 filing shows 311 new, 467 increased, 550 reduced and 311 closed positions. Its largest new stake was Berkshire Hathaway Class B: 646,010 shares worth $220M. The largest sale was Accenture, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Voloridge Investment Management's largest Q2 2023 buy was Berkshire Hathaway Class B: 646,010 shares worth $220M.
- Voloridge Investment Management added most to Coca-Cola in Q2 2023, an estimated $141M increase.
- Voloridge Investment Management's biggest Q2 2023 reduction was Medtronic, cutting an estimated $163M.
- Voloridge Investment Management fully exited Accenture in Q2 2023, selling an estimated $221M.
- Voloridge Investment Management's ten largest holdings make up 9.4% of its $21.2B portfolio in Q2 2023.
- Voloridge Investment Management opened 311 new positions and closed 311 in Q2 2023.
- Voloridge Investment Management's portfolio value rose 5.3% quarter-over-quarter to $21.2B.
Based on Voloridge Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.